Director to VP of Business Development, Biologic/Biosimilar Products

Prinston Pharmaceutical Inc.; New Jersey; On-site; USD 180,000 - 260,000; Full time

Job summary

Princeton Pharmaceuticals in the United States is seeking a strategic Director to VP of Business Development for Biologic/Biosimilar Products to lead the biosimilar portfolio, drive U.S. commercialization, and secure strategic partnerships.

The role requires deep biosimilar experience and cross-functional leadership in a US market context. The successful candidate will manage alliances, negotiate licensing or co-development deals, and shape market access and launch strategies for biosimilar

Qualifications

• Bachelor’s degree required; related field preferred.
• 10+ years in pharmaceutical industry with portfolio management.
• Direct U.S. biosimilar commercialization experience required.
• Strong analytical and strategic thinking in a global matrix.

Responsibilities

• Lead evaluation and identification of biosimilar products for the portfolio.
• Negotiate licensing, co-development, and co-promotion agreements.
• Build and manage strategic alliances with pharma, biotech, and research orgs.
• Partner with R&D, Regulatory, Medical Affairs, Legal, Finance, and Commercial teams to execute strategies.
• Develop U.S. market access and launch strategies for biosimilars.

Job description

Princeton Pharmaceuticals is seeking a strategic and results-driven Director to VP of Business Development, Biologic/Biosimilar Products to help establish and expand our biologics and biosimilars division. This high-impact leadership role will be responsible for identifying and evaluating portfolio opportunities, securing strategic partnerships, and driving U.S. commercialization strategies.

The ideal candidate brings deep knowledge of the biologics and biosimilars landscape, along with demonstrated success in U.S. pharmaceutical commercialization, market access, and strategic alliance management.

Key Responsibilities

• Lead evaluation and identification of new biologic and biosimilar products for the company’s portfolio; develop business cases and present recommendations to executive leadership
• Drive and lead negotiations for licensing, co-development, and co-promotion agreements with external partners
• Build and manage strategic alliances with pharmaceutical, biotech, and research organizations globally
• Partner cross-functionally with R&D, Regulatory, Medical Affairs, Legal, Finance, and Commercial teams to execute alliance and commercialization strategies
• Develop and implement U.S. market access and launch strategies for biosimilar products
• Maintain and manage a comprehensive database of current and future biosimilar pipeline opportunities
• Monitor industry trends, competitive branded biologics, and emerging formulations within the U.S. market
• Establish and lead robust forecasting and analytical processes for each portfolio asset, incorporating U.S.-specific considerations such as ASP dynamics, payer contracting, and reimbursement landscape
• Support long-term growth strategy aligned with U.S. business objectives

Qualifications

• Bachelor’s degree in Biology, Business, Marketing, or related field required; Master’s degree or higher preferred
• Direct experience in U.S. biosimilar commercialization REQUIRED
• Minimum 10 years of pharmaceutical industry experience, including at least 5 years managing a portfolio of projects
• Demonstrated success in U.S. pharmaceutical commercialization, including strong understanding of market access, pricing, payer, provider, and GPO dynamics
• Proven experience negotiating and executing licensing or strategic partnership agreements
• Strong analytical, strategic thinking, execution, and change management capabilities within a global matrix organization
• Excellent communication, negotiation, and presentation skills
• Self-motivated, independent, and capable of managing multiple complex initiatives simultaneously
• Proficiency in Microsoft Excel, Word, Project, and PowerPoint
• Willingness and ability to travel domestically and internationally